Company: RNST
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0000715072-25-000180
Chunk: 7

Company: RENASANT CORP
Filing Date: 2025-05-08
Form: 10-Q
Item: Item 1
Chunk 7
---
 activities: Provision for credit losses4,750 2,438 Depreciation, amortization and accretion8,360 8,097 Deferred income tax expense954 1,706 Proceeds from sale of MSR— 23,011 Gain on sale of MSR— (3,472)Funding of mortgage loans held for sale(303,158)(260,424)Proceeds from sales of mortgage loans held for sale328,897 250,399 Gains on sales of mortgage loans held for sale(4,500)(4,535)Debt prepayment benefit— (56)(Gains) losses on sales of premises and equipment(271)50 Stock-based compensation expense3,780 3,992 Decrease in other assets45,847 9,904 Decrease in other liabilities(20,025)(5,462)Net cash provided by operating activities106,152 65,057 Investing activitiesPurchases of securities available for sale(175,815)(46,975)Proceeds from sales of securities available for sale— 177,185 Proceeds from call/maturities of securities available for sale30,958 22,148 Proceeds from call/maturities of securities held to maturity25,831 24,159 Net increase in loans(171,186)(148,854)Purchases of premises and equipment(4,817)(3,296)Proceeds from sales of premises and equipment1,267 256 Net change in FHLB stock(222)5,120 Proceeds from sales of other assets746 132 Other, net1,183 93 Net cash (used in) provided by investing activities(292,055)29,968 Financing activitiesNet increase (decrease) in noninterest-bearing deposits137,394 (67,511)Net increase in interest-bearing deposits62,089 227,889 Net decrease in short-term borrowings(3)(199,456)Repayment of long-term debt— (245)Cash paid for dividends(14,270)(12,653)Net cash provided by (used in) financing activities185,210 (51,976)Net (decrease) increase in cash and cash equivalents(693)43,049 Cash and cash equivalents at beginning of period1,092,032 801,351 Cash and cash equivalents at end of period$1,091,339